Common Laboratory Values
| VALUE | NORMAL RANGE | UNIT |
|---|---|---|
| COMPLETE BLOOD COUNT | ||
| Red Blood Cell (RBC) | M: 4.5—5.5 F: 4.0—4.9 | x105/ml |
| White Blood Cell (WBC) | 4,500—10,000 | cells/mcL |
| Platelets | 100,000—450,000 | cells/mcL |
| Hemoglobin (Hgb) | M: 13.5—16.5 F: 12.0—15.0 Pregnant: 10—15 | g/dL |
| Hematocrit (Hct) | M: 41—50% F: 36—44% | |
| Mean Corpuscular Volume (MCV) | 80—100 | fL |
| DIFFERENTIAL COUNT | ||
| Neutrophils | 54—62% | |
| Eosinophils | 1—3% | |
| Basophils | 0—0.75% | |
| Lymphocytes | 25—33% | |
| Monocytes | 3—7% | |
| SERUM ELECTROLYTES | ||
| Sodium (Na+) | 135—145 | mEq/L |
| Potassium (K+) | 3.5—5.5 | mEq/L |
| Chloride (Cl-) | 95—105 | mEq/L |
| Calcium | 8.5—10.9 | mEq/L |
| Calcium, ionized | 2.24—2.46 | mEq/L |
| Magnesium (Mg) | 1.5—2.5 | mEq/L |
| Phosphorus (P) | 2.5—4.5 | mEq/L |
| URINALYSIS | ||
| Volume | 1,000—2,000 | mL/day |
| 30 | mL/hour | |
| Specific Gravity | 1.010—1.020 | |
| pH | 4.5—8 | |
| Casts | 1—2 | per high power field |
| Glucose | none | |
| Protein | none | |
| Uric Acid | F: 3.5—7.2 M: 2.6—6.0 | mg/dL |
| CHEMISTRY VALUES | ||
| Glucose | Adults: 70—110 | mg/dL |
| Blood Urea Nitrogen (BUN) | Adults: 7—18 Child: 5—20 Infant: 5—15 | mg/dL |
| Serum Creatinine | 0.6—1.35 | mg/dL |
| Creatinine Clearance (CrCl) | F: 85—132 M: 90—138 | mL/min |
| Albumin | 3.4—5.0 | g/dL |
| Bilirubin | <1.0 | mg/dL |
| Uric Acid | 3.5—7.5 | mg/dL |
| Creatine phosphokinase (CPK) | 21—198 | units/L |
| COAGULATION STUDIES | ||
| Prothrombin Time (PT) | 11—14 | seconds |
| Partial Thromboplastin Time (PTT) | 25—35 | seconds |
| International Normalized Ratio (INR) | 0.8—1.2 | |
| Activated Partial Thromboplastin Time (aPTT) | 1.5—2.5 | |
| Fibrinogen | 203—377 | mg/dL |
| Bleeding time | 1—6 | mins |
| LIPOPROTEINS AND TRIGLYCERIDES | ||
| Total Cholesterol | Ideal: below 200 Borderline: 200—240 High: above 240 | mg/dL |
| Low Density Lipoprotein (LDL) | <70 | mg/dL |
| High Density Lipoprotein (HDL) | <60 | mg/dL |
| Triglycerides | Normal: below 150 Borderline high: 150—199 High: 200—499 Very high: above 500 | mg/dL |
| SGOT (AST) | <35 | IU/L |
| SGPT (ALT) | <35 | IU/L |
| CARDIAC MARKERS | ||
| Troponin (CTN-1 or CTN-T) | Normal I: 0.03 Critical level I: above 1.5 Critical level T: 0.2 | ng/L |
| C-reactive protein | Below 0.8 | mg/dL |
| CD40 Ligand | 1.51—5.35 | mg/L |
| Creatinine Kinase (CK-MB) | 0—3 | mcg/L |
| ARTERIAL BLOOD GAS | ||
| pH | 7.35—7.45 | |
| Partial Pressure of CO2 (pCO2) | 35—45 | mmHg |
| Partial Pressure of O2 (pO2) | 80—100 | mmHg |
| Bicarbonate (HCO3) | 22—26 | mEq/L |
| Base Excess (BE) | -2—+2 | mEq/L |
| Oxygen Saturation (SaO2) | 95—100% | |
| THYROID FUNCTION STUDIES | ||
| Thyroid-Stimulating Hormone (TSH) | Adults: 0.2—5.4 Neonate: 3—20 | mU/L |
| Thyroxine (Total T4) | Adult: 5.4—11.5 Child: 6.4—13.3 | mcg/dL |
| Free Thyroxine (Total T4 F4) | Adult: 0.7—2.0 | ng/dL |
| Thyroid-Binding Globulin (TBG) | Male: 15—30 Female: 11.5—32.2 Pregnancy 1st Trimester: 19.8—64.7 2nd Trimester: 41.4—63.9 3rd Trimester: 31.0—73.6 | mcg/dL |
| Triiodothyronine (Total T3) | 75—200 | ng/dL |
| Free Triiodothyronine (FT3) | 260—480 | pg/dL |
| Thyroglobulin (Tg) Antibody | 5—25 | ng/mL |
| TUMOR MARKERS | ||
| CA 19-9 Tumor Markers | <37 | U/mL |
| CA 27.29 | Above 38 | Uml |
| CA 15.3 | Above 22 | Uml |
| CA 125 | 0—35 | Uml |
| Carcinoembryonic Antigen (CEA) | Above 5 | ng/mL |
| THERAPEUTIC SERUM DRUG LEVELS | ||
| Carbamazepine (Tegretol) | 4—10 | mcg/mL |
| Digoxin (Lanoxin) | 0.8—2.0 | ng/mL |
| Lithium (Eskalith) | 0.8—1.5 | mEq/L |
| Phenobarbital (Solfoton) | 15—40 | mcg/mL |
| Theophylline (Aminophylline) | 10—20 | mcg/mL |
| Valproic Acid (Depakene) | 50—100 | mcg/mL |